Researchers used ASCs from healthy donors and SSc patients to evaluate their effects on T-cell subsets, co-culturing them with PBMCs or purified CD4+ T cells under both direct cell-to-cell contact and transwell conditions. Here, CD4 is linked to systemic sclerosis.